Other
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five
CVS Health Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 1.1% to $11.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $10.67B to $11.49B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_securities_debt_maturities_afte_2b276aHistorical Data
13 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.17B | $6.81B | $6.7B | $6.82B | $7.32B | $7.41B | $8.03B | $8.97B | $10.47B | $10.67B | $10.98B | $11.37B | $11.49B |
| QoQ Change | — | -5.0% | -1.5% | +1.8% | +7.3% | +1.3% | +8.4% | +11.7% | +16.7% | +1.9% | +3.0% | +3.5% | +1.1% |
| YoY Change | — | — | — | -4.8% | +7.5% | +10.6% | +17.7% | +22.6% | +41.2% | +32.8% | +22.4% | +8.6% | +7.7% |
Range$6.7B – $11.49B
CAGR+17.0%
Avg YoY Growth+16.6%
Median YoY Growth+14.1%
Current Streak10 quarters growth
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five?
- CVS Health (CVS) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five of $11.49B in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five changed year-over-year?
- CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five increased by 7.7% year-over-year, from $10.67B to $11.49B.